Primary hepatic lymphoma in a female patient with Sjögren’s disease: A case report and literature review


Cite item

Full Text

Abstract

The paper describes a case of primary hepatic diffuse large B-cell lymphoma in a 52-year-old woman with a 27-year history of Sjögren’s disease. It gives the data available in the literature on the etiology, diagnosis, and morphological characteristics of primary hepatic lymphoma and touches upon the issues of differential diagnosis.

References

  1. Ziarkiewicz-Wroblewska B, Gornicka B, Suleiman W. Primary lymphoma of the liver: morphological and clinical analysis of 6 cases — success of aggressive treatment. Neoplasma. 2005;52(3):267-272.
  2. Civardi G Vallisa D, Berte R, Lazzaro A, Moroni CF, Cavanna L. Focal liver lesions in non-Hodgkin’s lymphoma: investigation of their prevalence, clinical significance and the role of Hepatitis C virus infection. Eur J Cancer. 2002;38(18):2382-2387.
  3. Lei KI. Primary Non-Hodgkins lymphoma of the liver. Leuk Lymphoma. 1998;29(3-4):293-299.
  4. Osborne BM, Butler JJ, Guarda LA. Primary lymphoma of the liver: ten cases and a review of the literature. Cancer. 1985;56(12):2902-2910.
  5. Bronowicki JP, Bineau C, Feugier P. Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology. 2003;37(4):781-787.
  6. De Renzo A, Perna F, Persico M. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin’s lymphoma. Eur J Haematol. 2008;81(1):51-57.
  7. Scoazec J, Degott C, Brousse N. Non-Hodgkin’s lymphoma presenting as a primary tumor of the liver: presentation diagnosis and outcome in eight patients. Hepatology. 1991;13(5):870-875.
  8. Noronha V, Shafi NQ, Obando JA, Kummar S. Primary non-Hodgkin’s lymphoma of the liver. Critical Rev Oncol Hematol. 2005;53(3):199-207.
  9. Gomyo H, Kagami Y, Kato H, Kawase T, Ohshiro A, Oyama T, Kamiya Y, Taji H, Nakamura S, Ogura M, Morishima Y. Primary hepatic follicular lymphoma: a case report and discussion of chemotherapy and favorable outcomes J Clin Exp Hematopathol. 2007;47(2):73-77.
  10. Murakami J, Fukushima N, Ueno H, Saito T, Watanabe T, Tanosaki R, Kobayashi Y, Matsuno Y, Tobinai K. Primary hepatic low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue type: a case report and review of the literature. Int J Hematol. 2002;75(1):85-90.
  11. Yu Y-D, Kim D-S Byun G-Y Lee JH, Kim IS, Kim CY, Kim YC, Suh SO. Primary hepatic marginal zone B cell lymphoma: a case report and review of the literature. Indian J Surg. 2013;75(Suppl 1):S331-S336.
  12. Paydas S, Demiryurek H, Ergin M, Acikalin A. Primary hepatic Burkitt’s lymphoma in an immunocompetent patient: case report and review of the literature. Open J Blood Dis. 2013;3(1):53-56.
  13. Cerban R, Gheorghe L, Becheanu G, Serban V, Gheorghe C. Primary focal T-cell lymphoma of the liver: a case report and review of the literature. J Gastrointestin Liver Dis. 2012;21(2):213-216.
  14. Ata AA, Kamel IA. Primary reticulum cell sarcoma of the liver. A case report. J Egypt Med Assoc. 1965;48(7):514-521.
  15. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29(1):252-260.
  16. Page R, Romaguera J, Osborne B. Primary hepatic lymphoma favorable outcome after combination chemotherapy. Cancer. 2001;92(8):2023-2029.
  17. Kikuma K, Watanabe J, Oshiro Y, Shimogama T, Honda Y, Okamura S, Higaki K, Uike N, Soda T, Momosaki S, Yokota T, Toyoshima S, Takeshita M. Etiological factors in primary hepatic B-cell lymphoma Virchows Arch. 2012;460(4):379-387.
  18. Lisker-Melman M, Pittaluga S, Pluda JM, Kleiner DE, Thompson P, Martin P, Yarchoan R, Di Bisceglie AM. Primary lymphoma of the liver in a patient with acquired immune deficiency syndrome and chronic hepatitis B. Am J Gastoenterol. 1989;84(11): 1445-1448.
  19. Freeman HJ. Hepatobiliary tract and pancreatic disorders in celiac disease. Can J Gastroenterol. 1997;11(1):77-81.
  20. Sato S, Masuda T, Oikawa H, Satoh T, Suzuki Y, Takikawa Y, Yamazaki K, Suzuki K, Sato S. Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol. 1999;94(6):1669-1673.
  21. Sutton E, Malatjalian D, Hayne OA, Hanly JG. Liver lymphoma in systemic lupus erythematosus. J Rheumatol. 1989;16(12):1584-1588.
  22. Tsuruta S, Enjoji M, Nakamuta M, Makihata T, Kotoh K, Sakai H, Ando BE, Nawata H. Primary hepatic lymphoma in a patient with Sjögren’s syndrome. J Gastroenterol. 2002;37(2):129-132.
  23. Tsutsumi Y, Deng YL, Uchiyama M, Kawano K, Ikeda Y. OPD4-positive T-cell lymphoma of the liver in systemic lupus erythematosus. Acta Pathol Jpn. 1991;41(11):829-833.
  24. Ye MQ, Suriawinata A, Black C Min AD, Strauchen J, Thung SN. Primary hepatic marginal zone B-cell lymphoma of mucosaassociated lymphoid tissue type in a patient with primary biliary cirrhosis. Arch Pathol Lab Med. 2000;124(4):604-608.
  25. Scerpella EG, Villareal AA, Casanova PF, Moreno JN. Primary lymphoma of the liver in AIDS: report of one new case and review of the literature. J Clin Gastroenterol. 1996;22(1):51-63.
  26. Weissmann DJ, Ferry JA, Harris NL. Posttransplantations lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol. 1995;103(6):748-755.
  27. Ribas Y, Rafecas A, Figueras J. Post-transplant lymphoma in a liver allograft. Transpl Int. 1995;8(6):488-491.
  28. Reichert CM, O’Leary TJ, Levens DL, Simrell CR, Macher AM. Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol. 1983;112(3):357-382.
  29. Haider FS, Smith R, Khan S. Primary hepatic lymphoma presenting as fulminant hepatic failure with hyperferritinemia: a case report. J Med Case Reports. 2008;2:279.
  30. Ohsawa M, Aozasa K, Horiuchi K. Malignant lymphoma of the liver: report of five cases and review of the literature. Dig Sci. 1992;37(7):1105-1109.
  31. Gazelle GS, Lee MJ, Hahn PF, Goldberg MA, Rafaat N, Mueller PR. US, CT, and MRI of primary and secondary liver lymphoma. J Comput Assist Tomogr. 1994;18(3):412-415.
  32. Santos ES, Raez LE, Salvatierra J, Morgensztern D, Shanmugan N, Neff GW. Primary hepatic non-Hodgkin’s lymphomas: case report and review of the literature. Am J Gastroenterol. 2003;98(12):2789-2793.
  33. Zafrani ES, Leclercq B, Vernant JP, Pinaudeau Y, Chomette G, Dhumeaux D. Massive blastic infiltration of the liver: a cause of fulminant hepatic failure. Hepatology. 1983;3(3):428-432.
  34. Kheyri Z, Asgari AA, Mehrjerdi AZ, Zamani F, Ajdarkosh H. Fulminant hepatic failure due to primary hepatic lymphoma: a case report. Middle East J Dig Dis. 2013;5(3):168-170.
  35. Smedby KE, Vajdic CM, Falster M, Engels EA, Martínez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC, Dal Maso L, Cocco , Maynadié M, Foretova L, Staines A, Brennan P, Davis , Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029-4038.
  36. Machida T, Takahashi T, Itoh T, Hirayama M, Morita T, Horita S. Reactive lymphoid hyperplasia of the liver: a case report and review of literature. World J Gastroenterol. 2007;13(40):5403-5407.
  37. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275-282.
  38. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937-1947.
  39. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359(22):2313-2323.
  40. Wilson WH, Dunleavy K, Pittaluga S, Hegde U, Grant N, Steinberg SM, Raffeld M, Gutierrez M, Chabner BA, Staudt L, Jaffe ES, Janik JE. Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. J Clin Oncol. 2008;26(16):2717-2724.
  41. Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood. 2009;113(24):6069-6076.
  42. Ruan J., Martin P, Furman RR, Lee SM, Cheung K, Vose JM, Lacasce A, Morrison J, Elstrom R, Ely S, Chadburn A, Cesarman E, Coleman M, Leonard JP. Bortezomib plus CHOP-Rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma. J Clin Oncol. 2010;29(6):690-697.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies